AFM
MRNA icon

Abbot Financial Management’s Moderna MRNA Stock Holding History

Abbot Financial Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,783
Closed -$217K – 115
2023
Q2 		$217K Sell
1,783
-161
-8% -$21.5K 0.14% 109
2023
Q1 		$299K Buy
1,944
+198
+11% +$32.7K 0.2% 98
2022
Q4 		$314K Buy
+1,746
New +$285K 0.21% 92
2022
Q3 		– Sell
-1,682
Closed -$240K – 118
2022
Q2 		$240K Hold
1,682
– – 0.15% 109
2022
Q1 		$290K Hold
1,682
– – 0.14% 112
2021
Q4 		$427K Buy
1,682
+94
+6% +$27.5K 0.19% 97
2021
Q3 		$611K Buy
1,588
+23
+1% +$8.48K 0.28% 78
2021
Q2 		$368K Sell
1,565
-734
-32% -$131K 0.16% 101
2021
Q1 		$301K Sell
2,299
-558
-20% -$80.9K 0.14% 103
2020
Q4 		$298K Buy
+2,857
New +$289K 0.17% 95

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Abbot Financial Management's MRNA Position: Q3 2023 in Review

Abbot Financial Management sold out of Moderna (MRNA) in Q3 2023, closing a stake of 1,783 shares — an estimated $217K sold.

Abbot Financial Management first reported a position in MRNA in Q4 2020 and held it in 10 quarters. The position peaked at $611K in Q3 2021. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Abbot Financial Management reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Abbot Financial Management sold 1,783 Moderna shares in Q3 2023, an estimated $217K.
  • Abbot Financial Management first reported a position in Moderna in Q4 2020 and held it in 10 quarters.
  • Abbot Financial Management's Moderna position peaked at $611K in Q3 2021.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Abbot Financial Management's 13F filing for Q3 2023, filed 13 Nov 2023.